Marina Meirelles Paes

Prof. Dr. Marina Meirelles Paes

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GBGustavo Roberto Villas Boas
Gustavo Roberto Villas Boas
RLRoseli Boerngen de Lacerda
Roseli Boerngen de Lacerda
MPMarina Meirelles Paes
Marina Meirelles Paes
PGPriscila Gubert
Priscila Gubert
WAWagner Luis da Cruz Almeida
Wagner Luis da Cruz Almeida
SOSilvia Oesterreich
Silvia Oesterreich

12 February 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Gustavo Villas-BoasGustavo Villas-Boas
Gustavo Villas-Boas
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
MPMarina Meirelles Paes
Marina Meirelles Paes
PCPablinny M. G. de Carvalho
Pablinny M. G. de Carvalho
VRVanessa C. Rescia
Vanessa C. Rescia
SOSilvia Oesterreich
Silvia Oesterreich
Serotonin (5-HT) receptors are found throughout central and peripheral nervous systems, mainly in brain regions involved in the neurobiology of anxiety and depression. 5-HT receptors are currently promising targets for discovering new drugs for treating disorders ranging from migraine to neuropsychiatric upsets, such as anxiety and depression. It is well described in the current literature that the brain expresses seven types of 5-HT receptors comprising eighteen distinct subtypes. In this article, we comprehensively reviewed 5-HT1-7 receptors. Of the eighteen 5-HT receptors known today, thirteen are G protein-coupled receptors (GPCRs) and represent targets for approximately 40% of drugs used in humans. Signaling pathways related to these receptors play a crucial role in neurodevelopment and can be modulated to develop effective therapies to treat anxiety and depression. This review presents the experimental evidence of the modulation of the “serotonergic receptosome” in the treatment of anxiety and depression, as well as demonstrating state-of-the-art research related to phytochemicals and these disorders. In addition, detailed aspects of the pharmacological mechanism of action of all currently known 5-HT receptor families were reviewed. From this review, it will be possible to direct the rational design of drugs towards new therapies that involve signaling via 5-HT receptors.

26 August 2020 in Molecules
Verified
Journal Article
Open access
PDF file
ACAline T. de Carvalho
Aline T. de Carvalho
MPMarina Meirelles Paes
Marina Meirelles Paes
Mila CunhaMila Cunha
Mila Cunha
GBGustavo C. Brandão
Gustavo C. Brandão
AMAna M. Mapeli
Ana M. Mapeli
Gustavo Villas-BoasGustavo Villas-Boas
Gustavo Villas-Boas
Fruit plants have been widely used by the population as a source of food, income and in the treatment of various diseases due to their nutritional and pharmacological properties. The aim of this study was to review information from the most current research about the phytochemical composition, biological and toxicological properties of four fruit species widely used by the world population in order to support the safe medicinal use of these species and encourage further studies on their therapeutic properties. The reviewed species are: Talisia esculenta, Brosimum gaudichaudii, Genipa americana, and Bromelia antiacantha. The review presents the botanical description of these species, their geographical distribution, forms of use in popular medicine, phytochemical studies and molecules isolated from different plant organs. The description of the pharmacological mechanism of action of secondary metabolites isolated from these species was detailed and toxicity studies related to them were reviewed. The present study demonstrates the significant concentration of phenolic compounds in these species and their anti-inflammatory, anti-tumor, photosensitizing properties, among others. Such species provide important molecules with pharmacological activity that serve as raw materials for the development of new drugs, making further studies necessary to elucidate mechanisms of action not yet understood and prove the safety for use in humans.


7 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Gustavo Villas-BoasGustavo Villas-Boas
Gustavo Villas-Boas
VRVanessa C. Rescia
Vanessa C. Rescia
MPMarina Meirelles Paes
Marina Meirelles Paes
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
MMManoel F. de Magalhães-Filho
Manoel F. de Magalhães-Filho
SOSilvia Oesterreich
Silvia Oesterreich
On March 11, 2020, the World Health Organization (WHO) officially declared the outbreak caused by the new coronavirus (SARS-CoV-2) a pandemic. The rapid spread of the disease surprised the scientific and medical community. Based on the latest reports, news, and scientific articles published, there is no doubt that the coronavirus has overloaded health systems globally. Practical actions against the recent emergence and rapid expansion of the SARS-CoV-2 require the development and use of tools for discovering new molecular anti-SARS-CoV-2 targets. Thus, this review presents bioinformatics and molecular modeling strategies that aim to assist in the discovery of potential anti-SARS-CoV-2 agents. Besides, we reviewed the relationship between SARS-CoV-2 and innate immunity, since understanding the structures involved in this infection can contribute to the development of new therapeutic targets. Bioinformatics is a technology that assists researchers in coping with diseases by investigating genetic sequencing and seeking structural models of potential molecular targets present in SARS-CoV2. The details provided in this review provide future points of consideration in the field of virology and medical sciences that will contribute to clarifying potential therapeutic targets for anti-SARS-CoV-2 and for understanding the molecular mechanisms responsible for the pathogenesis and virulence of SARS-CoV-2.